Neuralstem, Inc. is focused on developing and commercializing of treatments for central nervous system disease based on transplanting human neural stem cells and small molecule drugs. The Company has developed and maintain a portfolio of patents and patent applications that form the base of its research and development efforts in the areas of neural stem cell research, small molecule research, and related technologies.
04/10/11Neuralstem shares jump over 13% on new stem cell patent
16/12/10Neuralstem Receives FDA Approval to Start Phase Ia Trial for Depression Drug
14/09/10Study Shows Neuralstem’s Stem Cells May Have Application To Treating Stroke
Recent Sector News
U.S. stocks settled little changed again Thursday as investors took in mixed data, including a report that showed inflation over the past 12 months turned negative for the first time since 2009.
U.S. stock futures pointed slightly lower on Monday, retreating from records reached at the end of last week as investors looked ahead to data on home sales and testimony from U.S. Fed chairwoman Janet Yellen.
The promise of success is evident, proven by the company’s partnership with none other than Maureen McGrath, the renowned “sexpert” and the host of the popular Sunday Night Sex Show on CKNW Radio.
Enertopia (CSE:TOP) (OTCBB:ENRT) has been chosen to be featured in the MJIC Marijuana Index, the first and only marijuana sector benchmark index series, measuring the combined performance of globally listed marijuana stocks.
Enertopia Corporation (OTCBB:ENRT) (CSE:TOP) is launching the first product of its new sexual health line at the upcoming Vancouver Wellness Show, to be held this weekend at the Vancouver Convention Centre.
Investors interested in Neuralstem recently viewed
- Horizon Discovery Group (AIM: HZD) .
- ReNeuron (AIM: RENE) Leading stem cell company targeting areas of significant unmet medical need
- Clinigen Group PLC (AIM: CLIN) .
- e-Therapeutics plc (AIM: ETX) Systems Biology Drug Discovery
- Epistem Holdings Plc (AIM: EHP) Biotechnology company applying its expertise in epithelial stem cells